Navigation Links
Pharma IQ's Compound Management Survey Report

LONDON, March 14, 2012 /PRNewswire/ --

Pharma IQ has just published the results of an industry-wide Compound Management Survey, conducted recently among 4,000 compound management specialist with nearly half of those questioned having a library or sample management team responsible for biological materials or samples.

According to the survey results, 66.7 per cent of the professionals in the field cited three areas as primary concerns in their current role or department: the quality of samples, which can deteriorate during transport, the management of sample data and the huge need to construct new libraries to meet their new research.

With regard to the biggest challenges in handling biological samples or materials, the study revealed that quality perseverance, safeguarding of sample quality as well introducing an effective ID and tracking system was their key priority.

The survey was created as a part of the pre-conference research for Compound and Sample Management Forum taking place 21-23 May, 2012 in Amsterdam.

The results helped to shape the agenda and final speaker line-up which features Stuart Ratcliffe, Senior Scientist (Projects), Screening Sciences & Sample Management from AstraZeneca explaining the Automation in Compound Management employed at Astra Zeneca and Ling Santora, Senior Scientist, Bioresearch Centre from Abbott leading a session on The Biologics Pharmacy - Ensuring High Quality of Protein Reagents to Support Biologics Drug Discovery and Research at Abbott.

Other important topics expressed by survey respondents that will be discussed at the event include:

  • Management of in-vitro synthesized and in-vivo RNAi Reagents at the Drosophila RNAi Screening (Stephanie Mohr PhD, Director of the Drosophila RNAi Screening Center, Harvard Medical School)
  • Sample management workflows and supporting software (Janet Diratsaoglu, Principal Scientist, Roche)
  • Building a cDNA and RNAi library management system (Karen Billeci Scientific Manager, Assay & Automation Technology Group Genentech)
  • Library strategies: A model for academic/industrial collaboration in drug discovery: the rare paediatric brain tumour campaign at St. Jude Children's Research Hospital (Anang Shelat, Director, Lead Discovery Informatics and Compound Management, Department of Chemical Biology and Therapeutics
    St. Jude Children's Research Hospital)

To access the full survey report or to find out more about  Compound and Sample Management   please visit http://www.compoundmanagercom/NEWS, or call +44(0)20-7036-1300

Media contact: Joanna, +44(0)20-7368-9421, - Please contact for more information or images.

Press are invited to attend this important industry forum, if you would like to a complimentary press pass please email Joanna Checinska (

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2011 Financial Results on March 12, 2012
2. PharmAthene to Present at the 24th Annual ROTH Conference on Monday, March 12, 2012
3. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
4. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results
5. PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results
6. Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
7. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
8. Swedish Bactiguard to Enter Into an Exclusive Distribution Agreement With Cadila Pharmaceuticals
9. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2011 Financial Results on Wednesday, March 7, 2012
10. BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
11. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
Post Your Comments:
(Date:11/25/2015)... and HOLLISTON, Mass. , ... Inc. (Nasdaq: HART ), a biotechnology company developing ... CEO Jim McGorry will present at the ... 1, 2015 at 2:30 p.m. PT. The presentation will ... for 30 days. Management will also be available at ...
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman ... AngelList early in their initial angel funding process. Now, they are paying it ... to make early stage investments in the microbiome space. In this, they ...
Breaking Biology Technology:
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces today ... its Board of Directors. --> ... recently retiring from the partnership at TPG Capital, one ... with over $140 Billion in revenue.  He founded and ... all the TPG companies, from 1997 to 2013.  In ...
(Date:11/12/2015)... Mass. , Nov. 12, 2015  Arxspan ... Institute of MIT and Harvard for use of ... discovery information management tools. The partnership will support ... both biological and chemical research information internally and ... will be used for managing the Institute,s electronic ...
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
Breaking Biology News(10 mins):